Company: CSTL
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001447362-25-000069
Chunk: 17

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-05-05
Form: 10-Q
Item: Item 1
Chunk 17
---
 2024. The balance of our goodwill was $10.7 million as of March 31, 2025 and December 31, 2024. There were no accumulated impairments of goodwill as of March 31, 2025 or December 31, 2024.We had a single reportable segment consisting of a single operating segment where the operating segment and the single reporting unit where the same as of March 31, 2025 and December 31, 2024. See Note 14 for additional information on our reportable segment.

14

Table of ContentsCASTLE BIOSCIENCES, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)(UNAUDITED)

Other Intangible Assets, NetOur other intangible assets, net consisted of the following (in thousands):March 31, 2025 Gross carrying valueAccumulated amortizationNetWeighted-Average Remaining Life (in years)Developed technology$125,317 $(58,293)$67,024 10.5Assembled workforce563 (375)188 1.7Total other intangible assets, net$125,880 $(58,668)$67,212 December 31, 2024 Gross carrying valueAccumulated amortizationNetWeighted-Average Remaining Life (in years)Developed technology$125,317 $(29,996)$95,321 8.0Assembled workforce563 (347)216 1.9Total other intangible assets, net$125,880 $(30,343)$95,537 During the first quarter of 2025, we made the decision to discontinue our IDgenetix test offering, effective May 2025. As a result of this decision, we further revised the estimated useful life of the asset and determined that the intangible asset should be fully amortized as of March 31, 2025. This change resulted in an acceleration of amortization expense of approximately $20.1 million during the three months ended March 31, 2025. Amortization expense of intangible assets was $28.3 million and $2.2 million for the three months ended March 31, 2025 and 2024, respectively.

8. Other Accrued and Current Liabilities

Other accrued and current liabilities consisted of the following (in thousands): March 31, 2025December 31, 2024